Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $630,268 - $843,988
-6,850 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $613,486 - $672,738
6,850
6,850 $662,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Pacific Advisors, LP Portfolio

Follow First Pacific Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Pacific Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on First Pacific Advisors, LP with notifications on news.